Background: The current study aimed to investigate the prevalence, risk factors, endoscopic findings, and outcome of gastrointestinal bleeding in COVID-19 hospitalized patients. Materials and Methods: This study is a retrospective review of COVID-19 hospitalized patients with gastrointestinal bleeding from a large university hospital in southeast Iran. This study was conducted over one year from April 2020 to March 2021. Results: Out of 3563 COVID-19 inpatients with approximately equal sex distribution (52. 5% of men and 47. 5% of women), 80 (2. 24%) patients with a mean age of 58. 01 ±,20. 71 were identified with signs of gastrointestinal bleeding, including,melena (48. 8%), hemoglobin drop (42. 5%), fresh blood hematemesis (31. 3%), rectorrhagia (20%) and coffee ground emesis (10%). 52 patients (65%) had signs of gastrointestinal bleeding on admission, and 28 patients (35%) developed gastrointestinal bleeding during their hospital admissions, most of whom were men (63. 8%). Endoscopic characteristics were,gastric erosion (27. 7%), gastric ulcer (23%), duodenal ulcer (21. 5%), esophageal ulcer (12. 3%), and esophageal erosion (6. 1%) in upper gastrointestinal endoscopy. On colonoscopy, hemorrhoids (25%), mass lesions (16%), fissures (8. 3%), diverticular lesions (8. 3%), and polyps (8. 3%) were the most common findings. The overall mortality of the patients in the present study was 36. 2%. However, gastrointestinal bleedingrelated deaths were 7. 5%. Conclusion: Gastrointestinal bleeding was identified in 2. 24% of hospitalized COVID-19 patients, with gastroduodenal ulcers and erosions as the most common symptoms.